EPISODE · Oct 11, 2024 · 0 MIN
Evolus Study Unveils Millennial Botox Triumph
from AI Automation Minute · host Dr. Teri Fisher
This episode delves into a new study revealing that prabotulinumtoxinA, a type of Botox, is particularly effective among millennials. Dr. Rui Avelar, head of research and development at Evolus, shares insights from a post hoc analysis of 737 adults treated for glabellar lines. While over 90% of nonmillennials responded well, 100% of millennials saw positive results, with satisfaction rates exceeding 98% at various checkpoints. The episode explores why millennials may experience higher effectiveness and satisfaction, attributing it to their proactive approach to anti-aging and the mood-enhancing benefits of the treatment. Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare: 🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher📲 Follow on Instagram for automation tips: @DrTeriFisher💡 Discover AI tools for your practice: DrTeriFisher.com🎙 Listen to the long-form podcast: Anti-Aging Insights 👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder! #AIAutomationMinute #DrTeriFisher #HealthcareAI
Embed this episode
What this episode covers
This episode delves into a new study revealing that prabotulinumtoxinA, a type of Botox, is particularly effective among millennials. Dr. Rui Avelar, head of research and development at Evolus, shares insights from a post hoc analysis of 737 adults treated for glabellar lines. While over 90% of nonmillennials responded well, 100% of millennials saw positive results, with satisfaction rates exceeding 98% at various checkpoints. The episode explores why millennials may experience higher effecti...
Ready to play
Evolus Study Unveils Millennial Botox Triumph
No transcript for this episode yet
Similar Episodes
No similar episodes found.